The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca
Consulting or Advisory Role - BMS GmbH & Co. KG; Takeda
 
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; Novartis; Roche; Takeda
Speakers' Bureau - Janssen; Merck; MSD; Pfizer
Research Funding - AstraZeneca (Inst)
(OPTIONAL) Uncompensated Relationships - Achilles Therapeutics (Inst); AstraZeneca (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Olaparib, AZD1390, ceralasertib, saruparib and consolidation durvalumab (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer (NSCLC).
 
Alastair Greystoke
No Relationships to Disclose
 
Jamie B. Oughton
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst); SERVIER (Inst)
 
Sarah R Brown
Research Funding - Adlai Nortye (Inst); AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst)
 
Karl Butterworth
No Relationships to Disclose
 
Victoria Coyle
Honoraria - Gilead Sciences (I)
Consulting or Advisory Role - Merck
Speakers' Bureau - SERVIER
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); CellCentric (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Kevin Franks
Employment - GenesisCare
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche; Takeda
Research Funding - AstraZeneca (Inst)
Other Relationship - AstraZeneca; Boehringer Ingelheim; Elekta; Novartis; Pierre Fabre; Roche; Takeda
 
Adam Hassani
No Relationships to Disclose
 
Stephen Harrow
Honoraria - AstraZeneca; Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Takeda
 
Matthew Hatton
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer; Takeda
Travel, Accommodations, Expenses - Takeda
 
Crispin T. Hiley
Research Funding - Roche (Inst)
 
Jessica Kendall
No Relationships to Disclose
 
Rachel Phillip
No Relationships to Disclose
 
Matthew Norris
No Relationships to Disclose
 
Oluwaseun Ojo
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Paul Shaw
No Relationships to Disclose
 
Fiona Walker
No Relationships to Disclose
 
Huiqi Yang
No Relationships to Disclose
 
Anthony J. Chalmers
Honoraria - AstraZeneca; Bayer; Theranostics Health
Consulting or Advisory Role - AstraZeneca; Benevolent AI; Evgen
Research Funding - AstraZeneca (Inst); Benevolent AI (Inst)
 
Corinne Faivre-Finn
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca